<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>15</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2014</Year>
					<Month>02</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Non-Association of IL-16 rs4778889 T/C Polymorphism with Cancer Risk in Asians: a Meta-analysis</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>803</FirstPage>
			<LastPage>805</LastPage>
			<ELocationID EIdType="pii">28666</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>The IL-16 rs4778889 T/C polymorphism is associated with cancer risk. However, the results are conflicting.We performed this meta-analysis to derive a more precise estimation of the relationship. A comprehensiveliterature search was performed using PubMed, Embase and Web of Science databases. Odds ratio (OR) and95% confidence interval (CI) were used to assess the strength of association. A total of 6 studies including 1,603cases and 2,342 controls were identified. With all studies involved, results showed no statistically significantassociation between IL-16 rs4778889 T/C polymorphism and cancer risk (CC vs. CT+TT: OR=0.74, 95%CI:0.55-1.02, Ph=0.15; CC+CT vs. TT: OR=0.89, 95%CI: 0.72-1.10, Ph =0.03; CC vs. TT: OR=0.73, 95%CI: 0.53-1.00, Ph =0.08; CT vs. TT: OR=0.91, 95%CI: 0.79-1.05, Ph =0.08; C vs. T: OR=0.89, 95%CI: 0.74-1.07, Ph =0.02).In addition, the results were not changed when studies were stratified by cancer type. However, to verify ourfindings, it is essential to perform more well-designed studies with larger sample sizes in the future.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">IL-16</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">rs4778889</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Polymorphism</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Meta-analysis</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_28666_c60fee32fa297e3d61350181aac94c99.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
